会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Glutamate (ampa/kainate) receptor antagonists: N-substituted fused
azacycloalkylquinoxalinediones
    • 谷氨酸(ampa / kainate)受体拮抗剂:N-取代的稠合氮杂环烷基喹喔啉
    • US6057313A
    • 2000-05-02
    • US869515
    • 1997-06-05
    • Christopher Franklin BiggeThomas Charles MaloneRobert Michael SchelkunChung Stephen Yi
    • Christopher Franklin BiggeThomas Charles MaloneRobert Michael SchelkunChung Stephen Yi
    • C07D217/02C07D217/04C07D217/06C07D471/04A61K31/495C07D487/04
    • C07D471/04C07D217/02C07D217/04C07D217/06
    • Novel N-substituted azacycloalkyl ring fused 2,3-quinoxalinediones are disclosed represented by the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein R.sup.1 is hydrogen, alkyl or W-alkyl; X and Y are independently hydrogen, halogen, nitro, cyano, trifluoromethyl, SO.sub.2 CF.sub.3, SO.sub.2 R.sup.4, SO.sub.2 NR.sup.4 R.sup.5, alkyl, alkenyl, (CH.sub.2).sub.z CONR.sup.4 R.sup.5, (CH.sub.2).sub.z COOR.sup.4, or NHCOR.sup.4, wherein R.sup.4 and R.sup.5 are independently hydrogen, alkyl having 1 to 6 carbon atoms, cycloalkyl or W-alkyl, and z is an integer from 0 to 4; R.sup.2 is benzoyl, W, W-alkyl, COcycloalkyl, COalkyl-W, CONR.sup.3 alkyl, CONR.sup.3 -W, CONR.sup.3 alkyl-W, CSNR.sup.3 alkyl, CSNR.sup.3 alkyl-W, ##STR2## or a moiety derived from a common amino acid by removal of the --OH from the carboxyl group which is alpha to the amino, wherein --W is aryl, heteroaryl, or the heterocycles piperidinyl, piperazinyl, morpholinyl or pyrrolidinyl, wherein R.sup.3 is hydrogen, alkyl or W-alkyl; and m and n are independently 0, 1 or 2 provided that m+n is >1; provided that when R.sup.2 is benzoyl, ##STR3## or X is nitro, Y and R.sup.1 are H, m is 2 and n is 1;when R.sup.2 is ##STR4## X is nitro, Y and R.sup.1 are H and m is 2 and n is 1; or when R.sup.2 is ##STR5## X is bromo, Y and R.sup.1 are H, m is 1 and n is 2. The novel N-substituted azacycloalkyl ring fused 2,3-quinoxalinediones may be used, for example, as neuroprotective agents, for treatment of chronic neurodegenerative disorders, as anticonvulsants and in the treatment of schizophrenia, epilepsy, anxiety, pain and drug addiction.
    • 公开了由下式表示的新的N-取代的氮杂环烷基环稠合的2,3-喹喔啉二醇:或其药学上可接受的盐,其中R 1是氢,烷基或W-烷基; X和Y独立地是氢,卤素,硝基,氰基,三氟甲基,SO 2 CF 3,SO 2 R 4,SO 2 NR 4 R 5,烷基,烯基,(CH 2)z CONR 4 R 5,(CH 2)z COOR 4或NHCOR 4,其中R 4和R 5独立地是氢, 6个碳原子,环烷基或W-烷基,z是0-4的整数; R 2是苯甲酰基,W,W-烷基,CO环烷基,CO烷基-W,CONR 3烷基,CONR 3 -W,CONR 3烷基-W,CSNR 3烷基,CSNR 3烷基-W,或通过从羧基中除去-OH而衍生自常见氨基酸的部分 其中-W是芳基,杂芳基或杂环哌啶基,哌嗪基,吗啉基或吡咯烷基,其中R 3是氢,烷基或W-烷基; m和n独立地为0,1或2,条件是m + n大于1; 条件是当R 2为苯甲酰基或X为硝基时,Y和R 1为H,m为2且n为1; 当R 2为硝基时,Y和R 1为H,m为2,n为1; 或当R 2为X时,Y和R 1为H,m为1且n为2.新的N-取代的氮杂环烷基环稠合2,3-喹喔啉酮可用作例如神经保护剂,用于治疗慢性 神经退行性疾病,抗惊厥药和治疗精神分裂症,癫痫,焦虑,疼痛和药物成瘾。